SIMULECT- basiliximab injection, powder, for solution

Simulect by

Drug Labeling and Warnings

Simulect by is a Prescription medication manufactured, distributed, or labeled by Novartis Pharmaceuticals Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]


Trademark Results [Simulect]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SIMULECT
SIMULECT
79059709 3639864 Live/Registered
Novartis AG
2008-09-24
SIMULECT
SIMULECT
74665427 2122043 Live/Registered
NOVARTIS AG
1995-04-24
SIMULECT
SIMULECT
74342122 not registered Dead/Abandoned
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.)
1992-12-18

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.